JiangXi Tianxin Pharm Co Ltd (603235) — Capital Reinvestment Ratio
JiangXi Tianxin Pharm Co Ltd (603235) has a Capital Reinvestment Ratio of 0.92x as of December 2025, meaning it reinvests 1% of its operating cash flow (CN¥629.36 Million) in capital expenditures (CN¥580.68 Million). Check JiangXi Tianxin Pharm Co Ltd tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
JiangXi Tianxin Pharm Co Ltd Capital Reinvestment Ratio (2020–2025)
This chart tracks JiangXi Tianxin Pharm Co Ltd's Capital Reinvestment Ratio across 6 annual periods. For the full cash flow conversion analysis, see JiangXi Tianxin Pharm Co Ltd cash flow conversion.
Annual Capital Reinvestment Ratio for JiangXi Tianxin Pharm Co Ltd (2020–2025)
Year-by-year Capital Reinvestment Ratio for JiangXi Tianxin Pharm Co Ltd from 2020 to 2025. See 603235 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.92x | CN¥629.36 Million | CN¥580.68 Million | ▼ -56.8% |
| 2024 | 2.14x | CN¥499.66 Million | CN¥1.07 Billion | ▲ +190.7% |
| 2023 | 0.73x | CN¥729.21 Million | CN¥535.60 Million | ▲ +71.0% |
| 2022 | 0.43x | CN¥606.61 Million | CN¥260.50 Million | ▲ +63.1% |
| 2021 | 0.26x | CN¥818.63 Million | CN¥215.50 Million | ▲ +1.1% |
| 2020 | 0.26x | CN¥1.16 Billion | CN¥303.04 Million | — |